451 related articles for article (PubMed ID: 27050566)
21. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
22. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease.
Hira RS; Cowart JB; Akeroyd JM; Ramsey DJ; Pokharel Y; Nambi V; Jneid H; Deswal A; Denktas A; Taylor A; Nasir K; Ballantyne CM; Petersen LA; Virani SS
Am J Cardiol; 2016 Oct; 118(8):1144-1149. PubMed ID: 27553104
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
Chen DC; Singh GD; Armstrong EJ; Waldo SW; Laird JR; Amsterdam EA
Am J Cardiol; 2017 Apr; 119(8):1146-1152. PubMed ID: 28259239
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of lower extremity peripheral artery disease in veterans.
Willey J; Mentias A; Vaughan-Sarrazin M; McCoy K; Rosenthal G; Girotra S
J Vasc Surg; 2018 Aug; 68(2):527-535.e5. PubMed ID: 29588132
[TBL] [Abstract][Full Text] [Related]
25. Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
Olivier CB; Mulder H; Hiatt WR; Jones WS; Fowkes FGR; Rockhold FW; Berger JS; Baumgartner I; Held P; Katona BG; Norgren L; Blomster J; Patel MR; Mahaffey KW
JAMA Cardiol; 2019 Jan; 4(1):7-15. PubMed ID: 30540355
[TBL] [Abstract][Full Text] [Related]
26. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
27. Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
Govsyeyev N; Nehler M; Conte MS; Debus S; Chung J; Dorigo W; Gudz I; Krievins D; Mills J; Moll F; Norgren L; Piffaretti G; Powell R; Szalay D; Sillesen H; Wohlauer M; Szarek M; Bauersachs RM; Anand SS; Patel MR; Capell WH; Jaeger N; Hess CN; Muehlhofer E; Haskell LP; Berkowitz SD; Bonaca MP
J Vasc Surg; 2023 Apr; 77(4):1107-1118.e2. PubMed ID: 36470531
[TBL] [Abstract][Full Text] [Related]
28. High hemoglobin A
Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
[TBL] [Abstract][Full Text] [Related]
29. Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Infarction 50 (TRA2°P-TIMI 50).
Bonaca MP; Gutierrez JA; Creager MA; Scirica BM; Olin J; Murphy SA; Braunwald E; Morrow DA
Circulation; 2016 Mar; 133(10):997-1005. PubMed ID: 26826179
[TBL] [Abstract][Full Text] [Related]
30. Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry.
Abtan J; Bhatt DL; Elbez Y; Sorbets E; Eagle K; Reid CM; Baumgartner I; Wu D; Hanson ME; Hannachi H; Singhal PK; Steg PG; Ducrocq G;
Clin Cardiol; 2017 Sep; 40(9):710-718. PubMed ID: 28520087
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular Medication Use and Long-Term Outcomes of First Nations and Non-First Nations Patients Following Diagnostic Angiography: A Retrospective Cohort Study.
Dahl L; Schultz A; McGibbon E; Brownlie J; Cook C; Elbarouni B; Katz A; Nguyen T; Sawatzky JA; Sinclaire M; Throndson K; Prior HJ; Fransoo R
J Am Heart Assoc; 2019 Aug; 8(16):e012040. PubMed ID: 31405352
[TBL] [Abstract][Full Text] [Related]
32. Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study.
Ji Y; Wang B; Wu G; Zhang Y; Wang Q; Zhou M
Ther Adv Chronic Dis; 2023; 14():20406223231213262. PubMed ID: 38085917
[TBL] [Abstract][Full Text] [Related]
33. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis.
Brown LC; Johnson JA; Majumdar SR; Tsuyuki RT; McAlister FA
CMAJ; 2004 Nov; 171(10):1189-92. PubMed ID: 15534311
[TBL] [Abstract][Full Text] [Related]
34. Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease.
Al-Omran M; Lindsay TF; Major J; Jawas A; Leiter LA; Verma S;
Ann Vasc Surg; 2006 Sep; 20(5):555-63. PubMed ID: 16871436
[TBL] [Abstract][Full Text] [Related]
35. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
[TBL] [Abstract][Full Text] [Related]
36. Temporal Changes in Secondary Prevention and Cardiovascular Outcomes After Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
Søgaard M; Nielsen PB; Skjøth F; Eldrup N; Larsen TB
Circulation; 2021 Mar; 143(9):907-920. PubMed ID: 33300375
[TBL] [Abstract][Full Text] [Related]
37. Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction.
Klingelhoefer E; Bergert H; Kersting S; Ludwig S; Weiss N; Schönleben F; Grützmann R; Gäbel G
J Vasc Surg; 2016 Aug; 64(2):380-388.e1. PubMed ID: 27763266
[TBL] [Abstract][Full Text] [Related]
38. Contemporary Medical Management of Peripheral Artery Disease.
Bonaca MP; Hamburg NM; Creager MA
Circ Res; 2021 Jun; 128(12):1868-1884. PubMed ID: 34110910
[TBL] [Abstract][Full Text] [Related]
39. Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis.
Pastori D; Farcomeni A; Milanese A; Del Sole F; Menichelli D; Hiatt WR; Violi F
Thromb Haemost; 2020 May; 120(5):866-875. PubMed ID: 32369857
[TBL] [Abstract][Full Text] [Related]
40. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
